HIV viral non-suppression, associated factors and drug resistance profiles among women receiving PMTCT services in Addis Ababa, Ethiopia

Abstract Background High maternal HIV viral load is a key predictor of mother-to-child transmission (MTCT). In Ethiopia, viral non-suppression (VNS) and drug resistance data among pregnant and breastfeeding women are limited. This study assessed the prevalence of VNS, its associated factors, and drug resistance profiles in this population. Methods A cross-sectional study was conducted from September 2022 to March 2023 across 16 public health facilities in Addis Ababa, Ethiopia. A total of 496 HIV-positive pregnant and lactating women on ART were enrolled. Ten millilitres of venous blood were collected for viral load, CD4, haemoglobin and HIV-1 genotyping for selected samples. Drug resistance mutations were analysed using the Stanford HIV Drug Resistance Database (version 9.8). Data were analysed with SPSS v26. Results Magnitude of VNS (≥ 50 RNA copies/mL) was 11.3% (95% CI: 8.5–13.9); 2.2% had > 1000 copies/mL, and 9.1% had 50-1000 copies/mL. Poor/fair adherence (AOR:2.92; 95% CI: 1.2–7.12), WHO clinical stage II/III (AOR:4.2; 95% CI:1.86–9.47), and anaemia (< 11 g/dL) (AOR:4.36; 95% CI:1.32–14.39) were significantly associated with VNS. Low CD4 count correlated with high viremia ( P = 0.001). Drug resistance was found in 15.4% (2/13), with 18.2% (2/11) NNRTI and 9.1% (1/11) NRTI; while no PI or INSTI resistance or major mutations were found among women on TDF+3TC + DTG. Conclusions The proportion of women with​ high viral load (> 1000 copies/mL) was low (2.2%), while 11.3% had VNS (≥ 50 copies/mL), indicating a minority did not achieve optimal viral suppression. This may contribute to residual MTCT risk and underscores the need for adherence counselling, routine viral load monitoring, and anaemia screening and management. No major INSTI mutations were detected among the 11 women on DTG-based regimens, although larger studies with systematic genotyping are needed.

Authors

Institutions

Publication Details

Journal
AIDS Research and Therapy
Published
2026-11-14
DOI
https://doi.org/10.1186/s12981-026-00978-y
Primary Topic
HIV/AIDS Research and Interventions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

HIV viral non-suppression, associated factors and drug resistance profiles among women receiving PMTCT services in Addis Ababa, Ethiopia

Gutema Bulti, Dawit Assefa Arimide, Eleni Kidane, Patrik Medstrand et al.
AIDS Research and Therapy
HIV/AIDS Research and Interventions
article

HIV viral non-suppression, associated factors and drug resistance profiles among women receiving PMTCT services in Addis Ababa, Ethiopia

Gutema Bulti, Dawit Assefa Arimide, Eleni Kidane, Patrik Medstrand, Belete Woldesemayat, Jaleta Bulti, Aschale Worku, Kidist Zealiyas, Gemechu Tadesse, Minilik Demissie, Saro Abdella, Ajanaw Yizengaw, Yimam Getaneh, Getnet Hailu, Sisay Adane Megabo, Gadissa Gutema, Amelework Yilma Shiferaw
article en

Abstract

Abstract Background High maternal HIV viral load is a key predictor of mother-to-child transmission (MTCT). In Ethiopia, viral non-suppression (VNS) and drug resistance data among pregnant and breastfeeding women are limited. This study assessed the prevalence of VNS, its associated factors, and drug resistance profiles in this population. Methods A cross-sectional study was conducted from September 2022 to March 2023 across 16 public health facilities in Addis Ababa, Ethiopia. A total of 496 HIV-positive pregnant and lactating women on ART were enrolled. Ten millilitres of venous blood were collected for viral load, CD4, haemoglobin and HIV-1 genotyping for selected samples. Drug resistance mutations were analysed using the Stanford HIV Drug Resistance Database (version 9.8). Data were analysed with SPSS v26. Results Magnitude of VNS (≥ 50 RNA copies/mL) was 11.3% (95% CI: 8.5–13.9); 2.2% had > 1000 copies/mL, and 9.1% had 50-1000 copies/mL. Poor/fair adherence (AOR:2.92; 95% CI: 1.2–7.12), WHO clinical stage II/III (AOR:4.2; 95% CI:1.86–9.47), and anaemia (< 11 g/dL) (AOR:4.36; 95% CI:1.32–14.39) were significantly associated with VNS. Low CD4 count correlated with high viremia ( P = 0.001). Drug resistance was found in 15.4% (2/13), with 18.2% (2/11) NNRTI and 9.1% (1/11) NRTI; while no PI or INSTI resistance or major mutations were found among women on TDF+3TC + DTG. Conclusions The proportion of women with​ high viral load (> 1000 copies/mL) was low (2.2%), while 11.3% had VNS (≥ 50 copies/mL), indicating a minority did not achieve optimal viral suppression. This may contribute to residual MTCT risk and underscores the need for adherence counselling, routine viral load monitoring, and anaemia screening and management. No major INSTI mutations were detected among the 11 women on DTG-based regimens, although larger studies with systematic genotyping are needed.

AIDS Research and Therapy
Lund University (SE), Government of Ethiopia (ET), Ethiopian Public Health Institute (ET), Stanford Medicine (US), Stanford University (US)
HIV/AIDS Research and Interventions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon